
Dry eye disease affects millions of people and can significantly impact daily comfort and vision quality. While artificial tears and prescription medications help many individuals manage symptoms, some patients require more advanced treatments to restore the health of the eye’s surface. One innovative solution that has gained attention in recent years is the use of BioTissue® amniotic membrane therapy.
Dry eye occurs when the eyes either do not produce enough tears or the tears evaporate too quickly. Tears play an essential role in maintaining eye health by keeping the surface of the eye lubricated, protecting against infection, and supporting clear vision.
Several factors can contribute to dry eye disease, including:
When the tear film becomes unstable, inflammation and damage to the surface of the eye can develop. In more advanced cases, the cornea may struggle to heal properly, which is where regenerative treatments like amniotic membrane therapy can be beneficial.
BioTissue® amniotic membranes are a specialized treatment derived from the innermost layer of the placenta, known as the amniotic membrane. This tissue has been used in medicine for many years because of its powerful healing properties. These membranes are processed and preserved to create therapeutic grafts that can be applied to the surface of the eye. They contain natural growth factors and anti-inflammatory components that support tissue repair and regeneration. Because the amniotic membrane is naturally compatible with the body, it is well tolerated and promotes healing without causing irritation.
For patients with severe or chronic dry eye, the ocular surface can become inflamed and damaged. Traditional treatments may help manage symptoms, but they may not fully repair the underlying tissue.
BioTissue® amniotic membranes work by creating a protective environment that allows the eye to heal more effectively. When placed on the eye, the membrane acts as a biological bandage that helps:
This regenerative approach addresses the root causes of ocular surface damage rather than only relieving symptoms.
BioTissue® amniotic membranes are typically recommended for patients with moderate to severe ocular surface disease or those who have not experienced adequate relief from conventional dry eye treatments.
This therapy may be beneficial for individuals experiencing:
Our eye doctor will evaluate your symptoms, eye health, and treatment history to determine whether amniotic membrane therapy is appropriate for you.
BioTissue® amniotic membrane therapy offers a regenerative approach that helps heal the surface of the eye, reduce inflammation, and restore comfort. By promoting natural tissue repair, this advanced treatment provides hope for patients with moderate to severe dry eye who are seeking more effective and lasting relief.
Contact Morris Eye Associates to schedule a consultation and learn whether amniotic membrane therapy could be the right solution for your dry eye relief. Visit our office in Mendham, New Jersey, or call (862) 222-3800 to book an appointment today.